Hassan Mansouritorghabeh
Overview
Explore the profile of Hassan Mansouritorghabeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rostami M, Khoshnegah Z, Mansouritorghabeh H
Clin Appl Thromb Hemost
. 2021 Dec;
27:10760296211010973.
PMID: 34933579
SARS-CoV-2 in COVID-19 triggers abnormalities in coagulation parameters that can contribute to thrombosis. The goals of this research were to determine the levels of fibrinogen, D-dimer and FDP in COVID-19...
12.
Mousavi S, Arif S, Madadi S, Mansouritorghabeh H
Haemophilia
. 2021 Nov;
28(1):86-90.
PMID: 34837287
Introduction: Haemophilia is a well-known bleeding disorder that affects people worldwide. The main therapeutic strategy is regular infusion of exogenous factor VIII to ensure an optimal haemostatic standard. Morbidity and...
13.
Rostami M, Mansouritorghabeh H, Parsa-Kondelaji M
Clin Exp Med
. 2021 Nov;
22(3):347-357.
PMID: 34741678
The SARS-CoV-2 virus has spread to all corners of the world. Thrombosis is the cause of organ failure and subsequent death in COVID-19. The pathophysiology of thrombosis in COVID-19 needs...
14.
Mansouritorghabeh H
Expert Rev Hematol
. 2021 Apr;
14(5):467-472.
PMID: 33910448
: Rare bleeding disorders (RBDs) are a heterogeneous group of bleeding disorders. Consanguineous marriage is the favorite partnership in many communities among a population of more than a billion. Consanguineous...
15.
Rafieemehr H, Dorgalaleh A, Mansouritorghabeh H
Blood Res
. 2020 Nov;
PMID: 33232939
Background: Rare bleeding disorders include inherited coagulation disorders except for von Willebrand disease and hemophilia A and B. These disorders affect both men and women worldwide and mainly have an...
16.
Rostami M, Mansouritorghabeh H
Expert Rev Hematol
. 2020 Sep;
13(11):1265-1275.
PMID: 32997543
Introduction: COVID-19 disease has spread worldwide from December 2019 to the present day; the early stage of this disease can be associated with high D-dimer, prolonged PT, and elevated levels...
17.
Mansouritorghabeh H, de Laat B, Roest M
Blood Coagul Fibrinolysis
. 2020 Aug;
31(7):426-433.
PMID: 32833801
: Platelets play a pivotal role in controlling hemorrhaging from vessels of the human body. The impairment of platelets may lead to the development of bleeding manifestations. Unraveling the precise...
18.
Mansouritorghabeh H, Mohades S
Cardiovasc Hematol Disord Drug Targets
. 2020 Jul;
20(3):185-190.
PMID: 32611303
Objective: Development of inhibitors in hemophilia A and B comprise significant challenge for patients, hematologists, and health provider systems. It has recommended by the World Federation of Hemophilia (WFH) to...
19.
Rezaieyazdi Z, Mansouritorghabeh H
Clin Appl Thromb Hemost
. 2020 Jun;
26:1076029620913951.
PMID: 32598171
Nowadays, the development of factor VIII and IX inhibitors in patients with hemophilia is considered as the most challenging in the treatment of hemophilia. Immune tolerance induction (ITI) therapy is...
20.
Mansouritorghabeh H
Int J Hematol Oncol Stem Cell Res
. 2019 Dec;
13(4):172-173.
PMID: 31871590
No abstract available.